Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
<p><strong>Context:</strong> The cardiovascular (CV) safety of oral bisphosphonates (oBP) is uncertain.</p> <p><strong>Objective:</strong> Determine the risk of CV events in oBP users referred for bone mineral density (BMD) testing compared...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2020
|